Clinical trial Recruiting at 1 site Interventional Ages 18 to 30

taVNS and social attention in healthy adults

Official title: The Effect and Mechanism of taVNS in Modulating Human Social Attention

Run by University of Electronic Science and Technology of China · NCT07798349 · Data updated 2026-11-12

This study tests whether non-invasive taVNS can boost interest in social stimuli and whether changes involve oxytocin in healthy adults.

More Healthy Adult trials

Quick facts

Study typeInterventional
Ages18 Years to 30 Years
SexAll
Enrollment120 (estimated)
SponsorUniversity of Electronic Science and Technology of China
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedNovember 30, 2026
Study endsNovember 30, 2026
Registry record updatedSeptember 1, 2026
Trial IDNCT07798349 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults without neurological or psychiatric disorders, not using psychotropic medications, with baseline data within normal ranges.

Probably not a fit

Individuals with certain neurological/psychiatric conditions or those whose baseline data are extreme may not benefit from taVNS in this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This placebo-controlled, single-blind study examines if non-invasive taVNS applied to the ear can enhance attention to social versus non-social stimuli and whether any effects are linked to changes in oxytocin levels. Participants undergo baseline eye-tracking tasks, complete psychological questionnaires, receive taVNS or sham stimulation at different ear sites, and then repeat behavioral and physiological measurements. The trial compares left, right, and bilateral tragus stimulation to determine which site yields the strongest effects on social attention and oxytocin release. Exclusion criteria include neurological or psychiatric history and outlier baseline data. The study is conducted at the University of Electronic Science and Technology of China in Chengdu.

Why it matters

Potential benefit: If successful, taVNS could become a non-invasive way to modulate social attention in contexts where social processing is affected.

How similar studies have gone: Previous research with taVNS and social-cognition metrics has shown promising signals of effect, though findings are preliminary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Healthy adults

Exclusion Criteria:

* History of past or current neurological/psychiatric disorders;
* Use of psychotropic medications (including nicotine and alcohol)
* Visual impairments
* Baseline data exceeds ±3 SD from mean

Where it's running

  • School of Life science and Technology, University of Electronic Science and Technology of China
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.